Ziff Davis Q2 2025 slides: Revenue growth accelerates to 9.8%, organic growth returns

Ziff Davis (NASDAQ:ZD) reported strong Q2 2025 results, with revenue increasing 9.8% year-over-year to $352.2 million and adjusted EBITDA up 11.8% to $107.7 million. The digital media company achieved a significant turnaround by returning to 4% organic revenue growth, contrasting with negative organic growth in the prior year and a challenging Q1. This performance led to a 3.96% stock increase, with the company reaffirming its full-year guidance and maintaining a robust balance sheet with a low 0.5x leverage ratio, positioning it for continued execution and potential strategic acquisitions.

Analysis

Ziff Davis (NASDAQ:ZD) demonstrated a significant operational turnaround in its Q2 2025 results, reversing a trend of underperformance. The company reported a 9.8% year-over-year revenue increase to $352.2 million and an 11.8% rise in adjusted EBITDA to $107.7 million, directly fueling a 3.96% stock price increase on the day of the announcement. The most critical metric was the return to positive organic growth of 4%, a stark contrast to the -4% contraction in the same quarter of the prior year and a welcome recovery from the Q1 2025 earnings miss. Growth was broad-based, with the Advertising and Performance Marketing segment expanding 15.5% and four of the five business segments posting strong revenue gains, led by Health & Wellness (+15.7%) and Connectivity (+14.2%). A minor 0.9% revenue dip in the Cybersecurity & Martech segment was offset by an improved adjusted EBITDA margin in that unit. The company's financial position is a key strength, with a low net debt of $275 million and a conservative leverage ratio of 0.5x adjusted EBITDA, providing substantial capacity for strategic M&A. While quarterly free cash flow saw a slight increase, the year-to-date figure declined significantly to $21.9 million from $72.5 million due to working capital changes, a point requiring scrutiny. Management's decision to reaffirm full-year 2025 guidance signals confidence in sustaining this recovery, projecting mid-single-digit growth in key metrics.

Key Decisions for Investors

• The return to 4% organic growth and strength across most segments suggests the company's turnaround strategy is gaining traction, warranting a re-evaluation for investors who may have been cautious following previous underperformance.
• Investors should closely monitor free cash flow generation in the upcoming quarters, as the significant year-to-date decline due to working capital is a notable divergence from the strong profitability metrics.
• With a conservative 0.5x leverage ratio and a stated interest in M&A, the potential for strategic, accretive acquisitions represents a key forward-looking catalyst that could drive growth beyond the current guidance.